[1]
“A retrospective analysis to estimate trough concentrations of teicoplanin in patients with suspected or documented Gram-positive infections”, Braz. J. Pharm. Sci., vol. 59, p. e21077, Apr. 2023, doi: 10.1590/s2175-97902023e21077.